Screening programmes are designed to save lives through early diagnosis of cancer, but they also lead to misdiagnosed results and the overtreatment of harmless lumps.
A new study by Southampton University researchers has found that these negative outcomes for patients cancel out up to half of the benefit that others get from living longer lives.